In the last week, Pfizer/BioNTech and Moderna both announced results from two COVID-19 Phase 3 clinical trials showing efficacy of greater than 90 percent. According to company press releases, the trials showed no significant safety issues. (Full publication of the...
MILL VALLEY, Calif. and NEW YORK – May 11, 2020 – New research shows that more than a third of U.S. employees say their level of trust in their organizations has changed during the COVID-19 pandemic, with equal levels reporting gains...
Around the globe, we are navigating unprecedented territory. In response to the coronavirus 2019 pandemic, borders have closed, Main Streets have shuttered and millions of people are working from home—many alongside their children, who are figuring out how to go to...